Skip to main content
Image
Kirsteen-Maclean

Kirsteen Maclean

PhD, Senior Director of Biomarker and Translational Strategy, Ultivue Inc.

Kirsty Maclean has 20 years of leadership experience addressing academic, biotech, clinical research organizations (CRO) and pharmaceutical industries through clinical/technical communication, sales support, and strategic market intelligence. Previously Kirsty held leadership roles in commercial development and scientific communications at CodexDNA, Defines (now part of AstraZeneca), Nanostring Technologies and ThermoFisher Scientific. Prior to industry, Kirsty spent 8 years as a post-doctoral researcher and staff scientist at St. Jude Children’s Research Hospital, and to date has over 35 peer reviewed publications and book chapters. She holds a PhD in Hematology and a BS (Hons) in Biochemistry.

Published Pieces by Kirsteen Maclean

This white paper highlights the value of an integrated ISP-in situ hybridization (ISH) workflow for co-detection of protein and RNA targets on a single FFPE tissue section.

당신의 글을 소개하고 싶나요?
우리는 여기에 소개할 더 훌륭한 작가들을 찾고 있습니다. 제출물을 보내주시면 연락드리겠습니다!
당신이 보는 것과 같나요?
받은 편지함으로 직접 전달되는 더 많은 Knowledge Pathway 콘텐츠를 받아보세요. 언제든지 구독을 취소하세요.